Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis

References

• Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss post mortem. Neurology. 2007;68:1576–82. Epub 2007/05/09.
   PubMed Web of Science ®Google Scholar
• Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary Lateral Sclerosis - Clinical Features, Neuropathology and Diagnostic Criteria. Brain. 1992;115:495–520.
   PubMed Web of Science ®Google Scholar
• Rowland LP. Primary lateral sclerosis: disease, syndrome, both or neither?J Neurol Sci. 1999;170:1–4.
   PubMed Web of Science ®Google Scholar
• Swash M, Desai J, Misra VP. What is primary lateral sclerosis?J Neurol Sci. 1999;170:5–10.
   PubMed Web of Science ®Google Scholar
• Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Crevier-Buchman L, Salachas F, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain. 2001;124:1989–99.
   PubMed Web of Science ®Google Scholar
• Zhai P, Pagan F, Statland J, Butman JA, Floeter MK. Primary lateral sclerosis: a heterogeneous disorder composed of different subtypes?Neurology. 2003;60:1258–65.
   PubMed Web of Science ®Google Scholar
• Singer MA, Kojan S, Barohn RJ, Herbelin L, Nations SP, Trivedi JR, et al. Primary Lateral Sclerosis: clinical and laboratory features in 25 Patients. Journal of Clinical Neuromuscular Disease. 2005;7:1–9. Epub 2005/09/01.
   PubMedGoogle Scholar
• Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology. 2006;66:647–53.
   PubMed Web of Science ®Google Scholar
• Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle & Nerve. 2007;35:291–302. Epub 2007/01/11.
   PubMed Web of Science ®Google Scholar
• Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Archives of Neurology. 2007;64:232–6.
   PubMedGoogle Scholar
• Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology. 2009;72:1948–52.
   PubMed Web of Science ®Google Scholar
• Floeter MK, Mills R. Progression in primary lateral sclerosis: a prospective analysis. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2009;10:339–46. Epub 2009/11/20.
   PubMed Web of Science ®Google Scholar
• Soraru G, Ermani M, Logroscino G, Palmieri A, D’Ascenzo C, Orsetti V, et al. Natural history of upper motor neuron-dominant ALS. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010;11:424–9. Epub 2009/11/26.
   PubMed Web of Science ®Google Scholar
• Grace GM, Orange JB, Rowe A, Findlater K, Freedman M, Strong MJ. Neuropsychological functioning in PLS: a comparison with ALS. The Canadian Journal of Neurological Sciences. 2011;38:88–97. Epub 2010/12/16.
   PubMed Web of Science ®Google Scholar
• Brugman F, Veldink JH, Franssen H, de Visser M, de Jong JM, Faber CG, et al. Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes. Archives of Neurology. 2009;66:509–14. Epub 2009/04/15.
   PubMedGoogle Scholar
• Visser J, van den Berg Vos RM, Franssen H, van den Berg LH, Wokke JH, de Jong JMV, et al. Disease course and prognostic factors of progressive muscular atrophy. Archives of Neurology. 2007;64:522–8.
   PubMedGoogle Scholar
• Kim WK, Liu X, Sandner J, Pasmantier M, Andrews J, Rowland LP, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 2009;73:1686–92. Epub 2009/11/18.
   PubMed Web of Science ®Google Scholar
• van den Berg-Vos RM, Visser J, Kalmijn S, Fischer K, de Visser M, de Jong V, et al. A Long-term Prospective Study of the Natural Course of Sporadic Adult-Onset Lower Motor Neuron Syndromes. Archives of Neurology. 2009; 66:751–7.
   PubMedGoogle Scholar
• Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72:1087–94. Epub 2009/03/25.
   PubMed Web of Science ®Google Scholar
• Raaphorst J, de Visser M, van Tol MJ, Linssen WHJP, van der Kooi AJ, de Haan RJ, et al. Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy. J Neurol Neurosur Ps. 2011;82:170–5.
   PubMed Web of Science ®Google Scholar
• Cosottini M, Giannelli M, Siciliano G, Lazzarotti G, Michelassi MC, del Corona A, et al. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology. 2005;237:258–64. Epub 2005/09/27.
   PubMed Web of Science ®Google Scholar
• Sach M, Winkler G, Glauche V, Liepert J, Heimbach B, Koch MA, et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain. 2004;127:340–50.
   PubMed Web of Science ®Google Scholar
• van der Graaff MM, Sage CA, Caan MWA, Akkerman EM, Lavini C, Majoie CB, et al. Upper and extra-motor neuron involvement in early motor neuron disease: a diffusion tensor imaging study. Brain. 2011;134:1211–28.
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Pullman SL, Shungu DC, Chan S, Hays AP, Del Bene ML, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology. 2004;62:1753–7. Epub 2004/05/26.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, Tang MX, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology. 2007;68:1402–10.
   PubMed Web of Science ®Google Scholar
• Floyd AG, Yu QP, Piboolnurak P, Tang MX, Fang Y, Smith WA, et al. Transcranial magnetic stimulation in ALS: utility of central motor conduction tests. Neurology. 2009;72:498–504. Epub 2009/02/11.
   PubMed Web of Science ®Google Scholar
• Turner MR, Scaber J, Goodfellow JA, Lord ME, Marsden R, Talbot K. The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci. 2010;294:81–5.
   PubMed Web of Science ®Google Scholar
• Aydogdu I, Tanriverdi Z, Ertekin C. Dysfunction of bulbar central pattern generator in ALS patients with dysphagia during sequential deglutition. Clin Neurophysiol. 2011;122: 1219–28.
   PubMed Web of Science ®Google Scholar
• Kollewe K, Munte TF, Samii A, Dengler R, Petri S, Mohammadi B. Patterns of cortical activity differ in ALS patients with limb and/or bulbar involvement depending on motor tasks. Journal of Neurology. 2011;258:804–10. Epub 2010/12/04.
   PubMed Web of Science ®Google Scholar
• Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, Nations SP, et al. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology. 1999;53:1071–6.
   PubMed Web of Science ®Google Scholar
• Rosenfeld J, Chang SW, Jackson CE, Elchami Z, Barohn RJ. Lower Extremity Amyotrophic Diplegia (LAD): a new clinical entity in the spectrum of motor neuron disease. Neurology. 2002;58:411–2.
   PubMedGoogle Scholar
• Muzyka IM, Dimachkie MM, Barohn RJ, Katz JS, Jackson CE, Wang YX, et al. Lower Extemity Amyotrophic Diplegia (LAD): Prevalence and Pattern of Weakness. Neurology. 2010;74:467.
   Google Scholar
• Turner MR, Gerhard A, Al-Chalabi A, Shaw CE, Hughes RAC, Banati RB, et al. Mills’ and other isolated upper motor neuron syndromes: in vivo study with C-11-(R)-PK11195 PET. J Neurol Neurosur Ps. 2005;76: 871–4.
   PubMed Web of Science ®Google Scholar
• Kiernan JA, Hudson AJ. Frontal lobe atrophy in motor neuron diseases. Brain. 1994;117:747–57. Epub 1994/08/01.
   PubMed Web of Science ®Google Scholar
• Abe K, Fujimura H, Toyooka K, Sakoda S, Yorifuji S, Yanagihara T. Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci. 1997;148:95–100. Epub 1997/05/01.
   PubMed Web of Science ®Google Scholar
• Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59:1077–9.
   PubMed Web of Science ®Google Scholar
• Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal?Neurology. 2003;60:1094–7.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2009;10:131–46. Epub 2009/05/23.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Goetz RR, Rabkin JG, Dalton K, McElhiney M, Hays AP, et al. A prospective cohort study of neuropsychological test performance in ALS. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010;11:312–20. Epub 2010/03/17.
   PubMed Web of Science ®Google Scholar
• Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005; 65:1774–7.
   PubMed Web of Science ®Google Scholar
• Farnikova K, Kanovsky P, Nestrasil I, Otruba P. Coexistence of Parkinsonism, dementia and upper motor neuron syndrome in four Czech patients. J Neurol Sci. 2010;296:47–54. Epub 2010/07/14.
   PubMed Web of Science ®Google Scholar
• Gamez J, Corbera-Bellalta M, Mila M, Lopez-Lisbona R, Boluda S, Ferrer I. Chorea-ballism associated with familial amyotrophic lateral sclerosis. A clinical, genetic, and neuropathological study. Movement disorders: official journal of the Movement Disorder Society. 2008;23:434–8. Epub 2007/12/12.
   PubMed Web of Science ®Google Scholar
• Gilbert RM, Fahn S, Mitsumoto H, Rowland LP. Parkinsonism and motor neuron diseases: 27 patients with diverse overlap syndromes. Movement disorders: official journal of the Movement Disorder Society. 2010;25:1868–75. Epub 2010/07/30.
   PubMed Web of Science ®Google Scholar
• Knirsch UI, Bachus R, Gosztonyi G, Zschenderlein R, Ludolph AC. Clinicopathological study of atypical motor neuron disease with vertical gaze palsy and ballism. Acta Neuropathologica. 2000;100:342–6. Epub 2000/08/31.
   PubMedGoogle Scholar
• Kovacs GG, Murrell JR, Horvath S, Haraszti L, Majtenyi K, Molnar MJ, et al. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Movement disorders: official journal of the Movement Disorder Society. 2009;24:1843–7. Epub 2009/07/18.
   PubMed Web of Science ®Google Scholar
• Pradat PF, Salachas F, Cartalat-Carel S, Lacomblez L, Patte N, Leforestier N, et al. Association of chorea and motor neuron disease. Movement Disord. 2002;17:419–20.
   PubMed Web of Science ®Google Scholar
• Inoue A, Kumon Y, Fujiwara S, Watanabe H, Fukumoto SY, Ohue S, et al. A case of emergency carotid endarterectomy for severe stenosis of the cervical internal carotid artery presenting with progressing stroke: importance of managing blood pressure postoperatively. Neurol Surg Tokyo. 2006;34:289–95.
   PubMedGoogle Scholar
• Averbuch-Heller L, Helmchen C, Horn AKE, Leigh RJ, Buttner-Ennever JA. Slow vertical saccades in motor neuron disease: correlation of structure and function. Ann Neurol. 1998;44:641–8.
   PubMed Web of Science ®Google Scholar
• Palmowski A, Jost WH, Osterhage J, Prudlo J, Kasmann B, Schimrigk K, et al. Disorders of eye movement in amyotrophic lateral sclerosis: report of two patients. Klinische Monatsblatter fur Augenheilkunde. 1995;206:170–2. Epub 1995/03/01.
   PubMedGoogle Scholar
• Okuda B, Yamamoto T, Yamasaki M, Maya K, Imai T. Motor Neuron Disease with Slow Eye Movements and Vertical Gaze Palsy. Acta Neurologica Scandinavica. 1992;85:71–6.
   PubMed Web of Science ®Google Scholar
• Donaghy C, Thurtell MJ, Pioro EP, Gibson JM, Leigh RJ. Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases. Journal of Neurology, Neurosurgery, and Psychiatry. 2011;82:110–6. Epub 2010/11/26.
   PubMed Web of Science ®Google Scholar
• Grosskreutz J, Kaufmann J, Fradrich J, Dengler R, Heinze HJ, Peschel T. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurology. 2006;6:17. Epub 2006/04/28.
   PubMed Web of Science ®Google Scholar
• van der Graaff MM, de Jong JM, Baas F, de Visser M. Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review. Neuromuscular Disorders. 2009;19:53–8. Epub 2008/12/17.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurology. 2011;10:75–82. Epub 2010/11/03.
   PubMed Web of Science ®Google Scholar
• McCluskey LF, Elman LB, Martinez-Lage M, van Deerlin V, Yuan WX, Clay D, et al. Amyotrophic Lateral Sclerosis-Plus Syndrome With TAR DNA-Binding Protein-43 Pathology. Archives of Neurology. 2009;66:121–4.
   PubMed Web of Science ®Google Scholar
• Ince PG, Evans J, Knopp M, Forster G, Hamdalla HHM, Wharton SB, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003;60:1252–8.
   PubMed Web of Science ®Google Scholar
• Geser F, Stein B, Partain M, Elman LB, McCluskey LF, Xie SX, et al. Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathologica. 2011;121:509–17. Epub 2011/01/13.
   PubMedGoogle Scholar
• Kobayashi Z, Tsuchiya K, Arai T, Yokota O, Yoshida M, Shimomura Y, et al. Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss. J Neurol Sci. 2010;298:70–7. Epub 2010/09/03.
   PubMed Web of Science ®Google Scholar
• Kosaka T, Fu YJ, Shiga A, Ishidaira H, Tan CF, Tani T, et al. Primary lateral sclerosis: upper motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration: immunohistochemical and biochemical analyses of TDP-43. Neuropathology: official journal of the Japanese Society of Neuropathology. 2012;32:373–84. Epub 2011/11/22.
   PubMed Web of Science ®Google Scholar
• Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM. Ubiquitin Deposits in Anterior Horn Cells in Motor Neuron Disease. Neuroscience Letters. 1988;93: 197–203.
   PubMed Web of Science ®Google Scholar
• Lowe J, Lennox G, Jefferson D, Morrell K, Mcquire D, Gray T, et al. A Filamentous Inclusion Body within Anterior Horn Neurons in Motor Neuron Disease Defined by Immunocytochemical Localization of Ubiquitin. Neuroscience Letters. 1988;94:203–10.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–3.
   PubMed Web of Science ®Google Scholar
• Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Bioph Res Co. 2006;351:602–11.
   PubMed Web of Science ®Google Scholar
• Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Archives of Neurology. 2008;65:636–41. Epub 2008/05/14.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know?Nature reviews. Neurology. 2011;7:603–15. Epub 2011/10/13.
   PubMed Web of Science ®Google Scholar
• Corcia P, Valdmanis P, Millecamps S, Lionnet C, Blasco H, Mouzat K, et al. Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations. Neurology. 2012;78:1519–26. Epub 2012/04/28.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathologica. 2012;124:339–52. Epub 2012/08/21.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61:427–34.
   PubMed Web of Science ®Google Scholar
• Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, et al. p62 positive, TDP-43-negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathologica. 2011;122:691–702. Epub 2011/11/22.
   PubMed Web of Science ®Google Scholar
• Troakes C, Maekawa S, Wijesekera L, Rogelj B, Siklos L, Bell C, et al. An MND/ALS phenotype associated with C9orf72 repeat expansion: Abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathology: official journal of the Japanese Society of Neuropathology. 2011. Epub 2011/12/21.
   Google Scholar
• Ince PG, Highley JR, Kirby J, Wharton SB, Takahashi H, Strong MJ, et al. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathologica. 2011;122:657–71.
   PubMed Web of Science ®Google Scholar
• Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH Jr. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol. 1998;43:703–10. Epub 1998/06/18.
   PubMed Web of Science ®Google Scholar
• Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropath Exp Neur. 1998;57:895–904.
   PubMed Web of Science ®Google Scholar
• Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, et al. Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients. PloS One. 2010;5.
   Google Scholar
• Bosco DA, Morfini G, Karabacak NM, Song YY, Gros-Louis F, Pasinelli P, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13:1396–1403.
   PubMed Web of Science ®Google Scholar
• Liu HN, Sanelli T, Horne P, Pioro EP, Strong MJ, Rogaeva E, et al. Lack of Evidence of Monomer/Misfolded Superoxide Dismutase-1 in Sporadic Amyotrophic Lateral Sclerosis. Ann Neurol. 2009;66:75–80.
   PubMedGoogle Scholar
• Kerman A, Liu HN, Croul S, Bilbao J, Rogaeva E, Zinman L, et al. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathologica. 2010;119:335–44.
   PubMed Web of Science ®Google Scholar
• Brotherton TE, Li YJ, Cooper D, Gearing M, Julien JP, Rothstein JD, et al. Localization of a toxic form of superoxide dismutase-1 protein to pathologically affected tissues in familial ALS. P Natl Acad Sci USA. 2012;109:5505–10.
   PubMed Web of Science ®Google Scholar
• Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, Manavis J, et al. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosur Ps. 2010;81:639–45.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Ansorge O, Strong M, Bilbao J, Zinman L, Ang LC, et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation. Acta Neuropathologica. 2011;122:87–98.
   PubMed Web of Science ®Google Scholar
• Baumer D, Hilton D, Paine SML, Turner MR, Lowe J, Talbot K, et al. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 2010;75:611–8.
   PubMed Web of Science ®Google Scholar
• Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, Ajroud K, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol. 2010;67:739–48. Epub 2010/06/03.
   PubMed Web of Science ®Google Scholar
• Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805–11.
   PubMed Web of Science ®Google Scholar
• Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68:1571–5. Epub 2007/05/09.
   PubMed Web of Science ®Google Scholar
• van den Heuvel MP, Mandl RCW, Kahn RS, Pol HEH. Functionally Linked Resting-State Networks Reflect the Underlying Structural Connectivity Architecture of the Human Brain. Hum Brain Mapp. 2009;30:3127–41.
   PubMed Web of Science ®Google Scholar
• Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative Diseases Target Large-Scale Human Brain Networks. Neuron. 2009;62:42–52.
   PubMed Web of Science ®Google Scholar
• Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW. Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome. Neuron. 2012;73: 1216–27.
   PubMed Web of Science ®Google Scholar
• Douaud G, Filippini N, Knight S, Talbot K, Turner MR. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain. 2011;134: 3470–9. Epub 2011/11/15.
   PubMed Web of Science ®Google Scholar
• Verstraete E, Veldink JH, Mandl RCW, van den Berg LH, van den Heuvel MP. Impaired Structural Motor Connectome in Amyotrophic Lateral Sclerosis. PloS One. 2011;6.
   Google Scholar
• Mohammadi B, Kollewe K, Samii A, Dengler R, Munte TF. Functional Neuroimaging at Different Disease Stages Reveals Distinct Phases of Neuroplastic Changes in Amyotrophic Lateral Sclerosis. Hum Brain Mapp. 2011;32:750–8.
   PubMed Web of Science ®Google Scholar
• Turner MR, Brockington A, Scaber J, Hollinger H, Marsden R, Shaw PJ, et al. Pattern of spread and prognosis in lower limb-onset ALS. Amyotroph Lateral Scler. 2010; 11:369–73.
   PubMed Web of Science ®Google Scholar
• Korner S, Kollewe K, Fahlbusch M, Zapf A, Dengler R, Krampfl K, et al. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle & Nerve. 2011;43:636–42. Epub 2011/04/13.
   PubMed Web of Science ®Google Scholar
• Chio A, Calvo A, Moglia C, Mazzini L, Mora G, group Ps*. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. Journal of Neurology, Neurosurgery, and Psychiatry. 2011;82:740–6. Epub 2011/03/16.
   PubMed Web of Science ®Google Scholar
• Fujimura-Kiyono C, Kimura F, Ishida S, Nakajima H, Hosokawa T, Sugino M, et al. Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 2011;82:1244–9. Epub 2011/09/17.
   PubMed Web of Science ®Google Scholar
• Gargiulo-Monachelli GM, Janota F, Bettini M, Shoesmith CL, Strong MJ, Sica RE. Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. European journal of neurology: the official journal of the European Federation of Neurological Societies. 2012;19:834–41. Epub 2012/01/18.
   PubMed Web of Science ®Google Scholar
• Kanouchi T, Ohkubo T, Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?J Neurol Neurosur Ps. 2012;83:739–45.
   PubMed Web of Science ®Google Scholar
• Ganesalingam J, Stahl D, Wijesekera L, Galtrey C, Shaw CE, Leigh PN, et al. Latent cluster analysis of ALS phenotypes identifies prognostically differing groups. PloS One. 2009;4:7107. Epub 2009/09/23.
   PubMed Web of Science ®Google Scholar
• Yang WC, Strong MJ. Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment. Amyotroph Lateral Scler. 2012;13:178–93.
   PubMed Web of Science ®Google Scholar
• Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neuro-degenerative Diseases. 2005;2:202–7. Epub 2006/08/16.
   PubMed Web of Science ®Google Scholar
• Muller FL, Song W, Jang YC, Liu Y, Sabia M, Richardson A, et al. Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production. Am J Physiol-Reg I. 2007;293:1159–68.
   PubMed Web of Science ®Google Scholar
• Bogdanov M, Brown RH, Matson W, Smart R, Hayden D, O’Donnell H, et al. Increased oxidative damage to DNA in ALS patients. Free Radical Bio Med. 2000;29:652–8.
   PubMed Web of Science ®Google Scholar
• Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, et al. Wild-type non-neuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113–7. Epub 2003/10/04.
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Boillee S, Roberts EA, Garcia ML, McAlonis-Downes M, Mikse OR, et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. P Natl Acad Sci USA. 2008;105:7594–9.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Martin LJ, Kuncl RW. Decreased Glutamate Transport by the Brain and Spinal-Cord in Amyotrophic Lateral Sclerosis. New Engl J Med. 1992;326:1464–8.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Martin L, Levey AI, Dykeshoberg M, Jin L, Wu D, et al. Localization of Neuronal and Glial Glutamate Transporters. Neuron. 1994;13:713–25.
   PubMed Web of Science ®Google Scholar
• Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A. 2002;99:1604–9. Epub 2002/01/31.
   PubMed Web of Science ®Google Scholar
• Beers DR, Henkel JS, Xiao Q, Zhao WH, Wang JH, Yen AA, et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. P Natl Acad Sci U S A. 2006;103:16021–6.
   PubMed Web of Science ®Google Scholar
• Beers DR, Henkel JS, Zhao WH, Wang JH, Huang AL, Wen SX, et al. Endogenous regulatory T-lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain. 2011;134:1293–314.
   PubMed Web of Science ®Google Scholar
• Zhao WH, Beers DR, Henkel JS, Zhang W, Urushitani M, Julien JP, et al. Extracellular Mutant SOD1 Induces Microglial-Mediated Motoneuron Injury. Glia. 2010;58:231–43.
   PubMed Web of Science ®Google Scholar
• Buratti E, Baralle FE. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Frontiers in Bioscience: a journal and virtual library. 2008;13:867–78. Epub 2007/11/06.
   PubMed Web of Science ®Google Scholar
• Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Human Molecular Genetics. 2010;19:46–64. Epub 2010/04/20.
   PubMed Web of Science ®Google Scholar
• Lagier-Tourenne C, Cleveland DW. Rethinking ALS: the FUS about TDP-43. Cell. 2009;136:1001–4. Epub 2009/03/24.
   PubMed Web of Science ®Google Scholar
• Nagai M, Abe K, Okamoto K, Itoyama Y. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neuroscience Letters. 1998;244:165–8.
   PubMed Web of Science ®Google Scholar
• Rabin SJ, Kim JM, Baughn M, Libby RT, Kim YJ, Fan YX, et al. Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology. Human Molecular Genetics. 2010;19:313–28.
   PubMed Web of Science ®Google Scholar
• Lin CLG, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2 a glutamate transporter, in amyotrophic lateral sclerosis. Neuron. 1998;20:589–602.
   PubMed Web of Science ®Google Scholar
• Aizawa H, Sawada J, Hideyama T, Yamashita T, Katayama T, Hasebe N, et al. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathologica. 2010;120:75–84.
   PubMed Web of Science ®Google Scholar
• Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature. 2004;427:801.
   PubMed Web of Science ®Google Scholar
• Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang XD, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–77.
   PubMed Web of Science ®Google Scholar
• Voigt A, Herholz D, Fiesel FC, Kaur K, Muller D, Karsten P, et al. TDP-43-Mediated Neuron Loss In Vivo Requires RNA-Binding Activity. PloS One. 2010;5.
   Web of Science ®Google Scholar
• Polymenidou M, Cleveland DW. The seeds of neurodegeneration: prion-like spreading in ALS. Cell. 2011;147: 498–508. Epub 2011/11/01.
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N. A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J Biol Chem. 2011;286:18664–72. Epub 2011/04/02.
   PubMed Web of Science ®Google Scholar
• Grad LI, Guest WC, Yanai A, Pokrishevsky E, O’Neill MA, Gibbs E, et al. Intermolecular transmission of superoxide dismutase-1 misfolding in living cells. Proc Natl Acad Sci U S A. 2011;108:16398–403. Epub 2011/09/21.
   PubMed Web of Science ®Google Scholar
• Munch C, O’Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. P Natl Acad Sci U S A. 2011;108:3548–53.
   PubMed Web of Science ®Google Scholar
• Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron. 2011;72:57–71. Epub 2011/10/11.
   PubMed Web of Science ®Google Scholar
• Ozdinler PH, Benn S, Yamamoto TH, Guzel M, Brown RH, Macklis JD. Corticospinal Motor Neurons and Related Subcerebral Projection Neurons Undergo Early and Specific Neurodegeneration in hSOD1(G93A) Transgenic ALS Mice. Journal of Neuroscience. 2011;31: 4166–77.
   PubMed Web of Science ®Google Scholar
• MacDonald JL, Fame RM, Azim E, Shnider SJ, Molyneaux BJ, Arlotta P, Macklis JD. Specification of cortical projection neurons: transcriptional mechanisms. Developmental neuroscience: a comprehensive reference. 2012.
   Google Scholar
• Molyneaux BJ, Arlotta P, Menezes JRL, Macklis JD. Neuronal subtype specification in the cerebral cortex. Nature Reviews Neuroscience. 2007;8:427–37.
   PubMed Web of Science ®Google Scholar
• Woodworth MB, Custo Greig L, Kriegstein AR, Macklis JD. SnapShot: cortical development. Cell. 2012; 151:918–918.e1.
   PubMedGoogle Scholar